Pathogenic variants within the JAG2 gene reported in patients with LGMD R27 encompass a diverse spectrum, including missense, nonsense and frameshift mutations, each contributing to the heterogeneous clinical phenotype observed in affected individuals (1–3). This evidence concerns the gene JAG2 and limb-girdle muscular dystrophy.